I agree with Davidal but there will be exceptions, I believe we could be (will) be one of them. Look @ SGEN good technology, good @ raising money-sugar daddy hedge funds and Genentech, that is what you aim for. There is a chance @ this, the blunders and bad luck are creating a lose, lose pricing structure. I believe the pre-clinical data on these high impacts CX-1837, which I believe to be done @ a pretty prestigious University..--.Nothing against Alberta, will open the door to a broad deal and maybe a buyout. JMHO.